Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 3 institutions in 1 country.
Karina Espinosa-MazariegoUnidad de Enfermedades Infecciosas, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
Zeus Saldaña-AhuactziUnidad de Enfermedades Infecciosas, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
Sara A OchoaUnidad de Enfermedades Infecciosas, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.ORCID 0000-0002-5299-759X
Bertha González-PedrajoDepartamento de Genética Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.ORCID 0000-0002-2125-2157
Miguel A CevallosCentro de Ciencias Genómicas, Programa de Genómica Evolutiva, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
Ricardo Rodríguez-MartínezUnidad de Enfermedades Infecciosas, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
Mariana Romo-CastilloCONACYT-Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.ORCID 0000-0003-4952-4772
Rigoberto Hernández-CastroDepartamento de Ecología de Agentes Patógenos, Hospital General Dr. Manuel Gea González, Ciudad de México 14080, Mexico.ORCID 0000-0002-5656-0942
Ariadnna Cruz-CórdovaUnidad de Enfermedades Infecciosas, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
Juan Xicohtencatl-CortesUnidad de Enfermedades Infecciosas, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.ORCID 0000-0003-2577-9973
Hospital Infantil de México Federico Gómez · MXUniversidad Nacional Autónoma de México · MXHospital General Dr. Manuel Gea Gonzalez · MX
Funding
Consejo Nacional de Ciencia y Tecnología 133451Hospital Infantil de México Federico Gómez HIM/2014/016 SSA.1110Hospital Infantil de México Federico Gómez HIM/2016/028 SSA.1240Hospital Infantil de México Federico Gómez HIM/2017/004 SSA.1300
6 · The paper itself
Abstract
The CS21 pilus produced by enterotoxigenic
aimThis study aimed to determine whether
methodsA kanamycin cassette was used to replace the
resultsBioinformatic alignment analysis of the LngA proteins showed hypervariable regions and clustered the clinical ETEC strains into three groups. Variations in amino acid residues affect the adherence percentages of recombinant ECBL strains with
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.